Atara Biotherapeutics Cash Flow Statement (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-84.66M	-93.56M	-88.11M	18.47M	-84.09M	-74.57M	-74.77M	-71.11M	-69.80M	-60.45M	-31.75M	-19.05M	-21.91M	-12.69M	38.01M	2.39M	-4.30M	-3.39M	-4.14M	-4.83M
Depreciation and Depletion (Quarter)			1.50M	1.40M	1.10M	0.90M	0.90M	0.90M	0.90M	0.90M	0.90M	0.70M	0.60M	0.50M	0.30M			0.10M
Share-based Compensation (Quarter)	13.76M	-38.59M	0.62M	14.12M	14.02M		0.09M	12.55M	11.14M		8.40M	6.34M	6.42M	5.85M	4.21M	0.40M	1.23M	1.52M	0.75M	0.39M
Asset Writedowns and Impairment (Quarter)															4.13M
Cash from Operations (Quarter)	-58.98M	-34.27M	-84.53M	-63.96M	-65.06M	-56.88M	-38.43M	-52.80M	-51.35M	-50.41M	-29.61M	-10.64M	-3.99M	-24.47M	-28.14M	-7.32M	-9.79M	-5.70M	-3.07M	-3.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.02M	0.02M					1.20M	1.25M	1.27M	1.06M	1.05M	1.05M	1.09M	0.93M	0.85M	0.96M	0.89M	0.88M	0.81M	0.17M
Depreciation & Amortization (CF) (Quarter)	2.30M	2.49M	1.59M	1.40M	1.40M	1.25M	1.21M	1.20M	1.21M	1.21M	1.39M	1.33M	1.23M	1.10M	1.79M	0.24M	0.04M	0.05M	0.03M	0.01M
Change in Working Capital
Change in Receivables (Quarter)		0.99M	-0.32M	-0.03M	-0.39M	39.97M	-39.82M	0.11M	-0.34M	33.95M	1.73M	-33.41M	-1.09M	0.15M	7.39M	-8.88M	1.91M	-0.66M	-1.25M	0.32M
Change in Inventory (Quarter)						1.59M	3.75M	2.52M	-1.27M	3.12M	6.38M	2.67M	-4.77M	0.16M	-10.65M
Change in Account Payables (Quarter)	4.35M	0.36M	-4.59M	1.20M	-1.38M	-4.45M	-1.89M	-0.89M	2.46M	-2.81M	-0.83M	2.40M	-3.11M	2.22M	-2.98M	-0.08M	-0.98M	-0.19M	0.51M	0.19M
Change in Accured Expenses (Quarter)	3.82M	2.94M	-0.57M	-8.26M	1.29M	9.61M	-8.75M	3.64M	1.87M	-2.91M	-5.81M	-1.78M	-2.85M	-2.06M	3.49M	-4.93M	-3.08M	-0.80M	-0.64M	0.07M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	1.12M	-6.89M	-0.65M	-3.57M	4.35M	-11.61M	0.16M	-7.18M	7.56M	-13.18M	-1.67M	1.60M	0.32M	-0.27M	-79.11M	79.11M	-4.91M	4.89M	0.01M	-0.21M
Investing Activities
Capital Expenditures (Quarter)	-2.40M	0.28M	2.60M	-2.47M	-0.10M	0.03M	0.19M	0.70M	0.28M	-2.22M		0.16M		0.09M
Sales of Property, Plant and Equipment (Quarter)																	0.04M	0.56M
Change in Acquisitions & Divestments (Quarter)	70.94M	54.52M	89.25M	77.14M	75.90M	50.68M	62.30M	65.72M	70.70M	9.99M	14.84M	7.22M	3.00M	3.47M	17.20M		0.00M	7.88M
Cash from Investing Activities (Quarter)	1.19M	-24.32M	60.22M	31.83M	59.70M	51.22M	-6.01M	49.48M	70.45M	9.94M	14.72M	7.20M	-16.66M	3.38M	17.20M	-5.07M	-2.42M	8.44M		-6.63M
Financing Activities
Other financing activities (Quarter)	5.21M	-5.21M	-0.10M	1.51M	-1.56M	-0.04M		0.75M	-0.76M			0.11M		0.12M				0.04M
Cash from Financing Activities (Quarter)	47.14M	51.47M	19.85M	1.16M	-0.21M	32.29M	0.23M	0.47M	-0.21M	1.51M	24.14M	-0.32M	35.79M	-0.33M	-0.25M	15.30M	1.05M	-0.00M	2.95M	4.83M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	46.36M	49.96M	20.54M	-0.02M		1.38M	0.64M	-0.05M		1.55M	9.37M	-0.03M					1.50M	-0.03M	2.95M	4.83M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-10.65M	-7.12M	-4.46M	-30.98M	-5.57M	26.63M	-44.20M	-2.84M	18.89M	-38.95M	9.25M	-3.77M	15.14M	-21.42M	-11.19M	2.92M	-11.16M	2.74M	-0.12M	-5.14M
Free Cash Flow (Quarter)	-56.58M	-34.55M	-87.13M	-61.49M	-64.96M	-56.91M	-38.62M	-53.50M	-51.63M	-48.18M	-29.61M	-10.80M	-3.99M	-24.56M	-28.14M	-7.32M	-9.79M	-5.70M	-3.07M	-3.34M
Net Cash Flow (Quarter)	-10.65M	-7.12M	-4.46M	-30.98M	-5.57M	26.63M	-44.20M	-2.84M	18.89M	-38.95M	9.25M	-3.77M	15.14M	-21.42M	-11.19M	2.92M	-11.16M	2.74M	-0.12M	-5.14M

Research Tools

Datasets

Plans

Developers

Atara Biotherapeutics ATRA Cash Flow Statement (2013-2026)

Research Tools

Datasets

Plans

Developers

Atara Biotherapeutics ATRA Cash Flow Statement (2013-2026)

Create an account

Sign In

Reset Password